CooperCompanies, a leading global medical device company, announced financial results for its fiscal second quarter ended April 30, 2024.

Sharps Technology, Inc. announces the signing of a 5-year, $200 million syringe Sales Agreement with Nephron Pharmaceuticals to complement the Company’s Asset Purchase Agreement to acquire the InjectEZ specialty syringe manufacturing assets in West Columbia, South Carolina.

JEOL Ltd. announces the release of the new electron microscope JEM-120i developed with the concepts of “Compact”, “Easy To Use”, and “Expandable” on May 30, 2024.

Senseonics Holdings, Inc., a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring systems for people with diabetes, announced plans to participate in the upcoming Sidoti Small Cap Conference, being held in virtually.

Helius Medical Technologies, Inc., a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced the first third-party reimbursement from a major insurance carrier for the Company’s Portable Neuromodulation Stimulator device.

Tandem Diabetes Care, Inc. and Dexcom, Inc., announced that the Tandem Mobi insulin pump with Control-IQ technology is now fully compatible with both the Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring Systems.